Intra-hepatic arterial drug delivery

Journal of Drug Targeting

Volumn 3, Issue 5, 1996, Pages 341-347

  Blesing, Claire H ^a   Kerr, David J ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; FLOXURIDINE; FLUCYTOSINE; FLUOROURACIL; FOLINIC ACID; MITOMYCIN C; ZINOSTATIN;

BILE DUCT DISEASE; CANCER; CANCER SURVIVAL; CHOLECYSTITIS; CLINICAL TRIAL; COLORECTAL CARCINOMA; DIARRHEA; DRUG MONITORING; DRUG UPTAKE; DUODENITIS; GASTRITIS; GENE THERAPY; HEPATIC ARTERY; HEPATITIS; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER CELL CARCINOMA; LIVER METASTASIS; MAXIMUM PERMISSIBLE DOSE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PEPTIC ULCER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; VOMITING;

EID: 0030062979     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/10611869608996825     Document Type: Review

References (63)

1. Allen-Mersh TG, Earlam S, Fordy C, Abrams K and Houghton J. (1994) Quality of life and survival with continuous hepaticartery floxuridine infusion for colorectal liver metastases. Lancet, 344, 1255-1260.
2. Anderson JH, Kerr DJ, Setanoians A, Cooke TG and McArdle CS. (1992a) A pharmacokinetic comparison of intravenous versus intra-arterial folinic acid. Br J Cancer, 65, 133-135.
3. Anderson JH, Kerr DJ, Cooke TG and McArdle CS. (1992b) A phase I study of regional 5-fluorouracil and systemic folinic acid for patients with colorectal liver metastases. Br J Cancer, 65, 913-915.
4. 18F-5-fluorouracil following hepatic arterial and intravenous infusion. Br J Radiol (Submitted for publication).
5. Campbell KA, Burns RC, Sitzmann JV, Lipsett PA, Grochow LB and Niederhuber JE. (1993) Regional chemotherapy devices: Effect of experience and anatomy on complications. J Clin Oncol, 11, 822-826.
6. Chang AE, Schneider PD, Sugarbaker PH, Simpson C, Culnane M and Steinberg SM. (1987) A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg, 206, 685-693.
7. Chen H-S G and Gross JF. (1980) Intra-arterial infusion of anticancer drugs: Theoretic aspects of drug delivery and review of responses. Cancer Treat Rep, 64, 31-40.
8. Collins JM. (1984) Pharmacologic rational for regional drug delivery. J Clin Oncol, 2, 498-504.
9. Cunningham VJ, Pike VW, Bailey D, Freemantle CAJ, Page BC, Jones AKP, Kensett MJ, Bateman D, Luthra SK and Jones T. (1991) A Method of studying pharmacokinetics in man at picomolar drug concentrations. Br J Clin Pharmac, 32, 167-172.
10. Dakhil S, Ensminger W, Cho K, Niederhuber J, Doan K and Wheeler R. (1982) Improved regional selectivity of hepatic arterial BCNU with degradable microspheres. Cancer, 50, 631-635.
11. de Takats PG, Kerr DJ, Poole CJ, Warren HW and McArdle CS. (1994) Hepatic arterial chemotherapy for metastatic colorectal carcinoma. Br J Cancer, 69, 372-378.
12. Dimitrakopoulou A, Strauss LG, Clorius JH, Ostertag H, Schlag P, Heim M, Oberdorfer F, Helus F, Haberkorn U and van Kaick G. (1993) Studies with positron emission tomography after systemic administration of fluorine-18-uracil in patients with liver metastases from colorectal carcinoma. J Nucl Med, 34, 1075-1081.
13. Dimitrakopoulou-Strauss A, Strauss LG, Schlag P, Helus F, Lorenz WJ, Maier-Borst W and van Kaick G. (1994) Prediction of therapy outcome in patients with liver metastases from colorectal carcinoma. Eur J Nuc Med, 21, 856.
14. Ensminger WD, Rosowsky A, Raso V, Levin DC, Glode M, Come S, Steele G and Frei E. (1978) A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2-deoxyuridine and 5-fluorouracil. Cancer Res, 38, 3784-3792.
15. Evans WE and Relling MV. (1989) Clinical pharmacokinetics-pharmacodynamics of anticancer drugs. Clin Pharmacokinetics, 16, 327-336.
16. 19F magnetic resonance spactroscopy in patients with colorectal cancer: a pilot study. Ann Oncol, 4, 597-602.
17. Former JG, Silva JS, Golbey RB, Cox EB and Maclean BJ. (1984) Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. Ann Surg, 199, 306-316.
18. Frei E and Canellos G. (1980) Dose: A critical factor in cancer chemotherapy Am J Med, 69, 585-594.
19. Goldberg JA, Kerr DJ, Willmott N, McKillop JH and McArdle CS. (1988) Pharmacokinetics and pharmacodymamics of Iocoregional 5-fluorouracil (S-FU) in advanced colorectal liver metastases. Br J Cancer, 57, 186-189.
20. Goldberg JA, Kerr DJ, Watson DG, Willmott N, Bates CD, McKillop JH and McArdle CS. (1990a) The pharmacokinetics of 5-fluorouracil administered by arterial infusion in advanced colorectal hepatic metastases. Br J Cancer, 61, 913-915.
21. Goldberg JA, Kerr DJ, Willmott N, McKillop JH and McArdle CS. (1990b) Regional chemotherapy for colorectal liver metastases: a phase II evaluation of targeted hepatic arterial 5-fluorouracil for colorectal liver metastases. Br J Surg, 77, 1238-1240.
22. Goldberg JA, Murray T, Kerr DJ, Willmott N, Bessent RG, McKillop JH and McArdle CS. (1991a) The use of angiotensin II as a potential method of targeting cytotoxic microspheres in patients with intrahepatic tumour. Br J Cancer, 63, 308-310.
23. Goldberg JA, Thomson JAK, Bradnam MS, Fenner J, Bessent RG, McKillop JH, Kerr DJ and McArdle CS. (1991b) Angiotensin II as a potential method of targeting cytotoxic-loaded microspheres in patients with colorectal liver metastases. Br J Cancer, 64, 114-119.
24. Goldberg JA, Kerr DJ, Blackie R, Whately TL, Pettit L, Kato T and McArdle CS. (1991c) Mitomycin C loaded microcapsules in the treatment of colorectal liver metastases. Pharmacokinetics of regionally administered particulate chemotherapy. Cancer, 67, 952-955.
25. Grage TB, Vassilopoulos PP, Shingleton WW, Jubert AV, Elias EG, Aust JB and Moss SE. (1979) Results of a prospective randomized study of hepatic artery infusion with 5-fluorouracil versus intravenous 5-fluorouracil in patients with hepatic metastases from colorectal cancer: A central oncology group study. Surgery, 86, 550-555.
26. Groupe d'etude et du traitment du carcinome hepatocellulaire. (1995) A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med, 332, 1256-1261.
27. 18F] uracil positron emission tomography (PET). Eur J Cancer, 29A, 1682-1686.
28. Hohn DC, Stagg RJ, Friedman MA, Hannigan JF, Rayner A, Ignoffo RJ, Acord P and Lewis BJ. (1989) A randomized trial of continuous intravenous versus hepatic intra arterial floxuridine in patients with colorectal cancer metastatic to the liver: The northern California oncology group trial. J Clin Oncol, 7, 1646-1654.
29. Hunt TM, Flowerdew ADS, Birch SJ, Williams JD, Mullee MA and Taylor I. (1990) Prospective randomized controlled trial of hepatic arterial embolization or infusion chemotherapy with 5-fluorouracil and degradable starch microspheres for colorectal liver metastases. Br J Surg, 77, 779-782.
30. Jenkins SA, Day DW, Mooney B, Devitt P, Taylor I and Shields R. (1984) The effect of vasopressin and hepatic artery ligation on the blood supply to normal and metastatic liver tissue. Br J Cancer, 50, 785-791.
31. Kemeny N, Daly J, Reichman B, Geller N, Botet J and Oderman P. (1987) Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. Ann Int Med, 107, 459-465.
32. Kemeny N, Niedzwiecki D, Shurgot B and Oderman P. (1989) Prognostic variables in patients with hepatic metastases from colorectal carcinoma. Cancer, 63, 742-747.
33. Kemeny N, Cohen A, Bertino JR, Sigurdson ER, Botet J and Oderman P. (1990) Continuous intrahepatic infusion of floxuridine and leucovorin through an implantable pump for the treatment of hepatic metastases from colorectal carcinoma Cancer, 65, 2446-2450.
34. Kerr DJ. (1989) 5-Fluorouracil and folinic acid: interesting biochemistry or effective treatment? Br J Cancer, 60, 807-808.
35. Kerr DJ and Kaye SB. (1991) Chemoembolism in cancer therapy. Critical Reviews in Cancer Ed. SD Brock, 8, 19-39.
36. Kerr DJ and Los G. (1993) Pharmacokinetic principles of locoregional chemotherapy. Cancer Surveys, 17, 105-122.
37. Konno T, Maeda H, Iwai K, Tashiro S, Maki S, Morinaga T, Mochinaga M, Hiraoka T and Yokoyama I. (1983) Effect of arterial administration of high molecular weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report. Eur J Clin Oncol, 19, 1053-1065.
38. Lokich JJ, Ahlgren JD, Gullo JJ, Philips JA and Fryer JG. (1989) A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: A mid-Atlantic oncology programme study. J Clin Oncol, 7, 425-432.
39. Lotze MT, Flickinger JC and Carr BI. Hepatobiliary neoplasms. In De Vita VT, Hellman S and Rosenberg SA (Eds), Cancer, Principles and Practice of oncology (Philadelphia: JB Lippincott Co.) pp 883-914.
40. Martin JK, O'Connell MJ, Wieand HS, Fitzgibbons RJ, Mailliard JA, Rubin J, Nagorney DM, Tschetter LK and Krook JE (1990) Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal carcinoma. A Randomized trial. Arch Surg, 125, 1022-1027.
41. Mayer RJ. (1992) Chemotherapy for metastatic colorectal carcinoma. Cancer, 70, 1414-1424.
42. MRC Colorectal cancer working party (1994). MRC Protocol CR05. A randomised trial of intravenous versus intrahepatic arterial 5-FU and leucovorin for colorectal liver metastases. Medical Research Council, MRC Cancer Trials Office, Cambridge UK CB2 2BW
43. Niederhuber JE, Ensminger W, Gyves J, Thrall J, Walker S and Cozzi E. (1984) Regional chemotherapy of colorectal cancer metastatic to the liver. Cancer, 53, 1336-1343.
44. Peters GJ, Lankelma J, Kok RM, Noordhuis P, van Groeningen CJ, van der Wilt CL and Meyer S. (1993) Prolonged retention of high concentrations of 5-fluorouracil in human and murine tumours as compared with plasma. Cancer Chemother Pharmacol, 31, 269-276.
45. Piedbois P, Buyse M, Rustum Y, Machover D, Erlichman C, Carlson RW, Valone F, Labianca R, Doroshow JH and Petrelli N. (1992) Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate. J Clin Oncol, 10, 896-903.
46. 19F nuclear magnetic resonance spectroscopy pharmacokinetics. J Clin Oncol, 8, 1868-1873.
47. Present CA, Wolf W, Waluch V, Wiseman C, Kennedy P, Blayney D and Brechner RR. (1994) Association of intratumoral pharmacokinetics of fluorouracil with clinical response. Lancet, 343, 1184-1187.
48. Price P and Grifiths J (1994) Tumour pharmacokinetics?-we do need to know. Lancet, 343, 1174-1175.
49. Rougier P, Ducreux M, Pignon JP, Elias D, Tigaud JM, Lumbroso J, Ruffle P and Lasser PH. (1991) Prognostic factors in patients with liver metastases from colorectal carcinoma treated with discontinuous intra-arterial hepatic chemotherapy. Eur J Cancer, 27, 1226-1230.
50. Rougier P, Laplanche A, Huguier M, Hay JM, Ollivier JM, Escat J, Salmon R, Julien M, Audy JCR, Gallot D, Gouzi JL, Pailler JL, Elisa D, Lacaine F, Roos S, Rotman N, Luboinski M and Lasser P. (1992) Hepatic arterial infusion of floxuridine in patients with liver metastases from colorecial carcinoma: Long term results of a prospective randomized trial. J Clin Oncol, 10, 1112-1118.
51. Safi F, Bittner R, Roscher R, Schuhmacher K, Gaus W and Beger GH (1989) Regional chemotherapy for hepatic metastases of colorectal carcinoma (continuous intraarterial versus continuous intraarterial/intravenous therapy.) Cancer, 64, 379-387.
52. Sasaki Y, Imaoka S, Hasegawa Y, Nakano S, Ishikawa O, Ohigashi H, Taniguchi K, Koyama H, Iwanaga T and Terasawa T. (1985) Changes in distribution of hepatic blood flow induced by intra-arterial infusion of angiotensin II in human hepatic cancer. Cancer, 55, 311-316.
53. Schlemmer HP, Semmler W, Bachert P, Hohenberger P, Schlag P and van Kaick G. (1991) Evaluation of early response parameters for in vivo F-19 MR spectroscopy in therapy monitoring of patients with liver metastases of colorectal carcinoma. Radiology, 181, 210.
54. Shepard KV, Levin B, Karl RC, Faintuch J, DuBrow RA, Hagle M, Cooper RM, Beschorner J and Stablein D. (1985) Therapy for metastatic colorectal carcinoma with hepatic artery infusion chemotherapy using a subcutaneous implanted pump. J Clin Oncol, 3, 161-169.
55. Stagg RJ, Lewis BJ, Friedman MA, Ignoffo RJ and Hohn DC. (1984) Hepatic arterial chemotherapy for colorectal cancer metastatic to the liver. Ann Int Med, 100, 736-743.
56. 19F NMR. Br J Cancer, 50, 113-117.
57. Strauss LG and Conti PS. (1991) The applications of PET in clinical oncolgy. J Nucl Med, 32, 623-648.
58. Sullivan RD, Norcross JW, Watkins E. (1964) Chemotherapy of metastatic liver cancer by prolonged hepatic artery infusion. N Engl I Med, 270, 321-7.
59. Wagner JS, Adson MA, van Heerden JA, Adson MH and Ilstrup DM (1984) The natural histøry of hepatic metastases from colorectal carcinoma. Ann Surg, 199, 502-508.
60. Wagner JG, Gyves JW, Stetson PL, Walker-Andrews SC, Wollner IS, Cochran MK and Ensminger WD. (1986) Steady-state non-linear pharmacokinetics of 5-fluorouracil during hepatic arterial and intravenous infusions in cancer patients. Cancer Res, 46, 1499-1506.
61. Warren HW, Anderson JH, O'Gorman P, Kane E, Kerr DJ, Cooke TG and McArdle CS. (1994) A phase II study of regional 5-fluorouracil infusion with intravenous folinic acid for colorectal liver metastases. Br J Cancer, 70, 677-680.
62. Weiss L, Grundmann, Torhorst J, Hartveit F, Moberg I, Eder M, Fenoglio-Preiser CM, Napier J, Home CHW, Lopez MJ, Shaw-Dunn RI, Sugar J, Davis JD, Day DW and Harlos JP. (1986) Haematogenous metastatic patterns in colonic carcinoma: An anylsis of 1541 necropsies. J Pathol, 150, 195-203.
63. 19F NMR spectroscopic pharmacokinetics in tumor-bearing humans and rabbits. Proc Natl Acad Sci, 67, 492-496.